Cargando…
The impact of different anti-vascular endothelial growth factor treatment regimens on reducing burden for caregivers and patients with wet age-related macular degeneration in a single-center real-world Japanese setting
OBJECTIVE: To describe the burden associated with different anti-vascular endothelial growth factor (VEGF) treatment strategies for wet age-related macular degeneration (wAMD) in a real-word setting in Japan. METHODS: Single-center, cross-sectional survey of caregivers of patients with wAMD performe...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5722328/ https://www.ncbi.nlm.nih.gov/pubmed/29220371 http://dx.doi.org/10.1371/journal.pone.0189035 |
_version_ | 1783284987706998784 |
---|---|
author | Hanemoto, Tsukasa Hikichi, Yusuke Kikuchi, Norimasa Kozawa, Tadahiko |
author_facet | Hanemoto, Tsukasa Hikichi, Yusuke Kikuchi, Norimasa Kozawa, Tadahiko |
author_sort | Hanemoto, Tsukasa |
collection | PubMed |
description | OBJECTIVE: To describe the burden associated with different anti-vascular endothelial growth factor (VEGF) treatment strategies for wet age-related macular degeneration (wAMD) in a real-word setting in Japan. METHODS: Single-center, cross-sectional survey of caregivers of patients with wAMD performed in a hospital in Mito-City, a rural area in Japan. Caregiver burden was evaluated using the Burden Index of Caregivers (BIC-11), and depressive symptoms were assessed by the Center for Epidemiologic Studies Depression scale. Retrospective medical chart review was conducted to monitor resource use and visual acuity outcomes in patients. The productivity loss of caregivers accompanying patients on hospital visits was estimated using the human capital method. RESULTS: Seventy-one patient-caregiver pairs were included. Most caregivers were female (74.6%), spouse/partner (54.9%), employed (46.5%), and the primary caregiver (85.9%). Patients received anti-VEGF treatment as follows: treat-and-extend (T&E; n = 42), switch (from as-needed [PRN] to T&E; n = 18), PRN (n = 10), and other (n = 1). Caregiver-related burden (total BIC-11 scores) were 4.29 (T&E) 4.60 (PRN), and 5.33 (switch) (p = NS). The mean number of hospital visits was lower with T&E than PRN (7.88 vs. 14.0 [p = 0.00674] in year 1 and 5.68 vs. 9.0 in year 2). For patients who switched from PRN to T&E, the mean number of hospital visits decreased from 13.21 to 7.43 (p<0.0001) in the first year after switch. The productivity loss associated with accompanying patients to the hospital was lower for caregivers of patients receiving T&E than PRN (mean differences: 74,456.04 JPY [p = 0.00284] in year 1 and 40843.14 JPY in year 2), and was also reduced for caregivers of patients who switched from PRN to T&E. CONCLUSION: wAMD treatment with anti-VEGF agents via T&E reduced hospital visits compared with PRN, where associated monitoring visits are necessary to provide good patient outcomes. T&E was associated with a reduction trend in caregiver burden, including time and costs. |
format | Online Article Text |
id | pubmed-5722328 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-57223282017-12-15 The impact of different anti-vascular endothelial growth factor treatment regimens on reducing burden for caregivers and patients with wet age-related macular degeneration in a single-center real-world Japanese setting Hanemoto, Tsukasa Hikichi, Yusuke Kikuchi, Norimasa Kozawa, Tadahiko PLoS One Research Article OBJECTIVE: To describe the burden associated with different anti-vascular endothelial growth factor (VEGF) treatment strategies for wet age-related macular degeneration (wAMD) in a real-word setting in Japan. METHODS: Single-center, cross-sectional survey of caregivers of patients with wAMD performed in a hospital in Mito-City, a rural area in Japan. Caregiver burden was evaluated using the Burden Index of Caregivers (BIC-11), and depressive symptoms were assessed by the Center for Epidemiologic Studies Depression scale. Retrospective medical chart review was conducted to monitor resource use and visual acuity outcomes in patients. The productivity loss of caregivers accompanying patients on hospital visits was estimated using the human capital method. RESULTS: Seventy-one patient-caregiver pairs were included. Most caregivers were female (74.6%), spouse/partner (54.9%), employed (46.5%), and the primary caregiver (85.9%). Patients received anti-VEGF treatment as follows: treat-and-extend (T&E; n = 42), switch (from as-needed [PRN] to T&E; n = 18), PRN (n = 10), and other (n = 1). Caregiver-related burden (total BIC-11 scores) were 4.29 (T&E) 4.60 (PRN), and 5.33 (switch) (p = NS). The mean number of hospital visits was lower with T&E than PRN (7.88 vs. 14.0 [p = 0.00674] in year 1 and 5.68 vs. 9.0 in year 2). For patients who switched from PRN to T&E, the mean number of hospital visits decreased from 13.21 to 7.43 (p<0.0001) in the first year after switch. The productivity loss associated with accompanying patients to the hospital was lower for caregivers of patients receiving T&E than PRN (mean differences: 74,456.04 JPY [p = 0.00284] in year 1 and 40843.14 JPY in year 2), and was also reduced for caregivers of patients who switched from PRN to T&E. CONCLUSION: wAMD treatment with anti-VEGF agents via T&E reduced hospital visits compared with PRN, where associated monitoring visits are necessary to provide good patient outcomes. T&E was associated with a reduction trend in caregiver burden, including time and costs. Public Library of Science 2017-12-08 /pmc/articles/PMC5722328/ /pubmed/29220371 http://dx.doi.org/10.1371/journal.pone.0189035 Text en © 2017 Hanemoto et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Research Article Hanemoto, Tsukasa Hikichi, Yusuke Kikuchi, Norimasa Kozawa, Tadahiko The impact of different anti-vascular endothelial growth factor treatment regimens on reducing burden for caregivers and patients with wet age-related macular degeneration in a single-center real-world Japanese setting |
title | The impact of different anti-vascular endothelial growth factor treatment regimens on reducing burden for caregivers and patients with wet age-related macular degeneration in a single-center real-world Japanese setting |
title_full | The impact of different anti-vascular endothelial growth factor treatment regimens on reducing burden for caregivers and patients with wet age-related macular degeneration in a single-center real-world Japanese setting |
title_fullStr | The impact of different anti-vascular endothelial growth factor treatment regimens on reducing burden for caregivers and patients with wet age-related macular degeneration in a single-center real-world Japanese setting |
title_full_unstemmed | The impact of different anti-vascular endothelial growth factor treatment regimens on reducing burden for caregivers and patients with wet age-related macular degeneration in a single-center real-world Japanese setting |
title_short | The impact of different anti-vascular endothelial growth factor treatment regimens on reducing burden for caregivers and patients with wet age-related macular degeneration in a single-center real-world Japanese setting |
title_sort | impact of different anti-vascular endothelial growth factor treatment regimens on reducing burden for caregivers and patients with wet age-related macular degeneration in a single-center real-world japanese setting |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5722328/ https://www.ncbi.nlm.nih.gov/pubmed/29220371 http://dx.doi.org/10.1371/journal.pone.0189035 |
work_keys_str_mv | AT hanemototsukasa theimpactofdifferentantivascularendothelialgrowthfactortreatmentregimensonreducingburdenforcaregiversandpatientswithwetagerelatedmaculardegenerationinasinglecenterrealworldjapanesesetting AT hikichiyusuke theimpactofdifferentantivascularendothelialgrowthfactortreatmentregimensonreducingburdenforcaregiversandpatientswithwetagerelatedmaculardegenerationinasinglecenterrealworldjapanesesetting AT kikuchinorimasa theimpactofdifferentantivascularendothelialgrowthfactortreatmentregimensonreducingburdenforcaregiversandpatientswithwetagerelatedmaculardegenerationinasinglecenterrealworldjapanesesetting AT kozawatadahiko theimpactofdifferentantivascularendothelialgrowthfactortreatmentregimensonreducingburdenforcaregiversandpatientswithwetagerelatedmaculardegenerationinasinglecenterrealworldjapanesesetting AT hanemototsukasa impactofdifferentantivascularendothelialgrowthfactortreatmentregimensonreducingburdenforcaregiversandpatientswithwetagerelatedmaculardegenerationinasinglecenterrealworldjapanesesetting AT hikichiyusuke impactofdifferentantivascularendothelialgrowthfactortreatmentregimensonreducingburdenforcaregiversandpatientswithwetagerelatedmaculardegenerationinasinglecenterrealworldjapanesesetting AT kikuchinorimasa impactofdifferentantivascularendothelialgrowthfactortreatmentregimensonreducingburdenforcaregiversandpatientswithwetagerelatedmaculardegenerationinasinglecenterrealworldjapanesesetting AT kozawatadahiko impactofdifferentantivascularendothelialgrowthfactortreatmentregimensonreducingburdenforcaregiversandpatientswithwetagerelatedmaculardegenerationinasinglecenterrealworldjapanesesetting |